A. Bossios (Stockholm, Sweden), M. Idzko (Vienna, Austria)
Late Breaking Abstract - Pharmacological characterization of T cell-induced broncho-constriction in vitro and in vivo
A. Mori (Sagamihara, Japan), S. Kouyama (Sagamihara, Japan), M. Yamaguchi (Sagamihara, Japan), C. Kumitani (Sagamihara, Japan), A. Ohtomo-Abe (Sagamihara, Japan), N. Fujita (Sagamihara, Japan), M. Iwata (Sagamihara, Japan), K. Nagayama (Sagamihara, Japan), K. Ryu (Sagamihara, Japan), Y. Nakamura (Sagamihara, Japan), Y. Tomita (Sagamihara, Japan), Y. Hamada (Sagamihara, Japan), H. Hayashi (Sagamihara, Japan), K. Watai (Sagamihara, Japan), Y. Kamide (Sagamihara, Japan), K. Sekiya (Sagamihara, Japan), Y. Fukutomi (Sagamihara, Japan), M. Taniguchi (Sagamihara, Japan), T. Ohtomo (Hachioji, Japan), O. Kaminuma (Chuo, Japan)
|    |
IL-37 ameliorates experimental asthma by inhibiting IL-1
A. Schroeder (Borstel, Germany), L. Lunding (Borstel, Germany), C. Vock (Borstel, Germany), B. Schaub (Munich, Germany), U. Zissler (Munich, Germany), H. Fehrenbach (Borstel, Germany), M. Wegmann (Borstel, Germany)
| |
Alamandine reduces eosinophilic inflammation in an experimental model of asthma
J. Gregório (Belo Horizonte, Brazil), G. Magalhães (Belo Horizonte, Brazil), G. Rodrigues-Machado (Belo Horizonte, Brazil), K. Gonzaga (Belo Horizonte, Brazil), A. Oliveira (Belo Horizonte, Brazil), F. Souza-Neto (Belo Horizonte, Brazil), B. Rezende (Belo Horizonte, Brazil), V. Pinho (Belo Horizonte, Brazil), L. Barcelos (Belo Horizonte, Brazil), R. Da Silva (Belo Horizonte, Brazil), R. Santos (Belo Horizonte, Brazil), M. Campagnole-Santos (Belo Horizonte, Brazil)
|  |
Omalizumab enhances the percentage of GARP cells in both regulatory and terminally differentiated effector Th cells in severe allergic asthmatics
J. Nieto-Fontarigo (Santiago de Compostela, Spain), F. Salgado-Castro (Santiago de Compostela, Spain), M. San-José-Capilla (Santiago de Compostela, Spain), J. Carreira-Villamor (Santiago de Compostela, Spain), L. Valdés-Cuadrado (Santiago de Compostela, Spain), A. Faraldo-García (Santiago de Compostela, Spain), M. García-González (Santiago de Compostela, Spain), C. Diego-Roza (Ferrol, Spain), P. Martín-Lancharro (Santiago de Compostela, Spain), J. Moure-González (Santiago de Compostela, Spain), T. Liñares-Mata (Pontevedra, Spain), E. Takkouche-Souilamas (Santiago de Compostela, Spain), P. Arias (Santiago de Compostela, Spain), M. Nogueira (Santiago de Compostela, Spain), F. González-Barcala (Santiago de Compostela, Spain)
| |
Immunogenicity of Mepolizumab in Patients with Severe Eosinophilic Asthma: Experience from the Clinical Development Program
H. Ortega (La Jolla, CA, United States of America), E. Meyer (Philadelphia, PA, United States of America), G. Brusselle (Ghent, Belgium), K. Asano (Kanagawa, Japan), R. Price (Stevenage, Hertfordshire, United Kingdom), C. Prazma (Research Triangle Park, NC, United States of America), F. Albers (Research Triangle Park, NC, United States of America), S. Yancey (Research Triangle Park, NC, United States of America), G. Gleich (Utah, United States of America)
| |
Dupilumab efficacy in asthma patients with comorbid chronic rhinosinusitis or nasal polyposis (CRS/NP) in LIBERTY ASTHMA QUEST
I. Pavord (Oxford, United Kingdom), L. Ford (Bellevue, United States of America), L. Sher (Rolling Hills Estates, United States of America), K. Rabe (Kiel, Germany), H. Park (Seoul, Republic of Korea), B. Cosio (Palma de Mallorca, Spain), M. Foster (Bridgewater, United States of America), H. Staudinger (Bridgewater, United States of America), J. Maroni (Tarrytown, United States of America), P. Rowe (Bridgewater, United States of America), N. Amin (Tarrytown, United States of America), G. Pirozzi (Bridgewater, United States of America), M. Ruddy (Tarrytown, United States of America), B. Akinlade (Tarrytown, United States of America), N. H. Graham (Tarrytown, United States of America), A. Teper (Bridgewater, United States of America)
| |
Tryptase loss-of-function mutations reduce tryptase expression and predict asthmatic response to anti-IgE therapy
D. Choy (South San Francisco, United States of America), N. Trivedi (San Francisco, United States of America), A. Dressen (South San Francisco, United States of America), M. Babina (Berlin, Germany), R. Ahuja (San Francisco, United States of America), T. Yi (South San Francisco, United States of America), J. Jackman (South San Francisco, United States of America), G. Ji (South San Francisco, United States of America), J. Hackney (South San Francisco, United States of America), L. Orozco-Guerra (South San Francisco, United States of America), D. Chang (South San Francisco, United States of America), G. Caughey (San Francisco, United States of America), B. Yaspan (San Francisco, United States of America)
| |
Systemic immunological changes following intravenous mesenchymal stromal cell infusion in stable COPD patients
J. Armitage (Perth, Australia), D. Tan (Perth, Australia), R. Troedson (Perth, Australia), P. Young (Perth, Australia), K. Lam (Perth, Australia), K. Shaw (Perth, Australia), M. Sturm (Perth, Australia), D. Weiss (Vermont, United States of America), Y. Moodley (Perth, Australia)
| |